Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Avadel Pharmaceuticals plc (AVDL)

5.88   -0.03 (-0.51%) 09-20 01:20
Open: 5.94 Pre. Close: 5.91
High: 6.12 Low: 5.65
Volume: 2,456,320 Market Cap: 342M
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. The company is headquartered in Dublin, Dublin and currently employs 144 full-time employees. The firm offers various drug delivery platforms, including Micropump, LiquiTime, Trigger Lock and Medusa. The firm offers its products in various categories, including hospital, including Bloxiverz, Vazculep and Akovaz, and pediatrics, including Karbinal ER, Cefaclor for Oral Suspension, AcipHex Sprinkle and Flexichamber. Bloxiverz is a drug used intravenously in the operating room for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery. Vazculep is used to treat clinically hypotension resulting primarily from vasodilation in the setting of anesthesia. Akovaz is indicated to treat clinically hypotension in the setting of anesthesia. Cefaclor is indicated for the treatment of otitis media, lower respiratory infections, pharyngitis and tonsillitis, urinary tract infections, and skin and skin structure infections, caused by susceptible organisms.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.127 - 6.159 6.159 - 6.187
Low: 5.578 - 5.612 5.612 - 5.642
Close: 5.821 - 5.882 5.882 - 5.934

Technical analysis

as of: 2020-09-18 4:28:22 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 8.83     One year: 10.54
Support: Support1: 5.20    Support2: 4.33
Resistance: Resistance1: 7.56    Resistance2: 9.02
Pivot: 6.13
Moving Average: MA(5): 5.67     MA(20): 6.52
MA(100): 8.00     MA(250): 7.25
MACD: MACD(12,26): -0.61     Signal(9): -0.59
Stochastic oscillator: %K(14,3): 27.24     %D(3): 18.59
RSI: RSI(14): 39.65
52-week: High: 13.49  Low: 3.25  Change(%): 31.5
Average Vol(K): 3-Month: 82799  10-Days: 137614

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
AVDL has closed above bottom band by 40.4%. Bollinger Bands are 31.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 18 Sep 2020
Avadel Pharmaceuticals PLC (AVDL) Stock: Buy, Hold, or Sell? - InvestorsObserver

Thu, 17 Sep 2020
Avadel Pharmaceuticals plc (AVDL) Is Worth A Look Now, Despite 156.95% Loss From High - Stocks Register

Thu, 17 Sep 2020
Avadel to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit - GlobeNewswire

Tue, 15 Sep 2020
An in-depth look at the Avadel Pharmaceuticals plc (AVDL) stock - Marketing Sentinel

Mon, 14 Sep 2020
Where Does Avadel Pharmaceuticals PLC (AVDL) Stock Fall in the Drug Manufacturers - Specialty & Generic Field? - InvestorsObserver

Thu, 10 Sep 2020
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Jumps 0.69%, But Additional Rally May Be Imminent - Marketing Sentinel

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 58
Shares Float (M) 38
% Held by Insiders 8.13
% Held by Institutions 39.87
Shares Short (K) 6,070
Shares Short P. Month (K) 5,540

Stock Financials

EPS 0.430
EPS Est This Year 1.160
EPS Est Next Year 0.250
Book Value (p.s.) 3.130
Profit Margin 38.70
Operating Margin -35.97
Return on Assets (ttm) -4.2
Return on Equity (ttm) 22.4
Qtrly Rev. Growth -42.5
Gross Profit (p.s.) 0.809
Sales Per Share 0.817
EBITDA (p.s.) -0.253
Qtrly Earnings Growth
Operating Cash Flow (M) -35
Levered Free Cash Flow (M) -35

Stock Valuations

PE Ratio 13.67
PEG Ratio
Price to Book value 1.88
Price to Sales 7.20
Price to Cash Flow -9.76

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.